1Bateman ED,Boushey HA,Bousquet J,et al.Can guideline -defined asthma control be achieved? The Gaining Optimal Asthma ControL study[J].Am J Respir Crit Care Med,2004,170(8):836-844.
3Nathan RA,Sorkness CA,Kosinski M,et al.Development of the asthma control test:a survey for assessing asthma control[J].J Allergy Clin Immunol,2003,111 (1):59 -65.
4Juniper EF,Svensson K,Mork AC,et al.Measuring health -related quality of life in adults during an acute asthma exacerbation[J].Chest,2004,125 (1):93-97.
6Cicutto LC,Downey GP.Biological markers in diagnosing,monitoring,and treating asthma:a focus on noninvasive measurements[J].AACN Clin Issues,2004,15 (1):97-111.
7Taylor DR.Nitric oxide as a clinical guide for asthma management[J].J Allergy Clin Immunol,2006,117 (2):259 -262.
8Carpagnano GE,Foschino BMP,Resta O,et al.Exhaled markers in the monitoring of airways inflammation and its response to steroid's treatment in mild persistent asthma[J].Eur J Pharmacol,2005,519 (1-2):175-181.
9Boushey HA,Sorkness CA,King TS,et al.Daily versus as -needed corticosteroids for mild persistent asthma[J].N Engl J Med,2005,352 (15):1519-1528.
二级参考文献6
1Nie HX,Yang J,Hu SP,et al.Effects of theophylline on CD4^+ lymphocyte,interleukin-5,and interferon gamma in induced sputum of asthmatic subjects[J].Acta Pharmacol Sin,2002,23 (3):267-272.
2Jatakanon A,Lim S,Barnes PJ.Changes in sputum eosinophils predict loss of asthma control[J].Am J Respir Crit Care Med,2000,161:64 -72.
3O'Connor GT,Sparrow D,Weiss ST.The role of allergy and nonspecific airway hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease[J].Am Rev Respir Dis,1989,140:225-252.
4Pizzichini E,Pizzichini MMM,Efthimiadis A,et al.Indices of airway inflammation in induced sputum:reproducibility and validity of cell fluid phase measurements[J].Am J Respir Crit Care Med,1996,154:808-817.
